Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente

KEVIN JOHNSON AND VIJAY AGGARWAL JOIN AUREON BIOSCIENCES TWO VETERAN LAB EXECUTIVES are back in the business. Kevin Johnson is now the Chairman at Aureon Biosciences Corporation and Vijay Aggarwal, Ph.D. is President and CEO. The fact that both men chose to join Aureon Biosciences will draw attention to the biotech firm. It is developing …

Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente Read More »

To access this post, you must purchase The Dark Report.

Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month